Board of Directors

George Fotiades has served as Aptar’s Chairman of the Board since 2018. He was most recently the President and CEO of Cantel Medical Corp from March 2019 until its acquisition by STERIS plc in June 2021. Previously, Mr. Fotiades was an operating partner in the healthcare practices of Five Arrows Capital Partners and Diamond Castle Holdings LLC, as well as a director of Cantel Medical Corp. He is currently a director of Prologis, Inc., and has served on Aptar’s Board of Directors since 2011.

Giovanna Kampouri Monnas is an advisor and is a member of the boards of directors of Puig S.L, Exea Ventures BV and the Hellenic Corporation of Assets and Participations S.A. She was previously a member of the Supervisory Board of Randstad Holding NV, and a director of Imerys S.A.  Her final executive role was the President of Benckiser International. Ms. Kampouri Monnas has served on the Board of Directors since 2010.

Andreas Kramvis is an operating partner at AEA Investors. He was previously Vice Chairman of Honeywell International and served as President and Chief Executive Officer of the Honeywell Performance Materials and Technologies group. He is a former Director of Axalta Coating Systems Ltd. Mr. Kramvis is also a director of several privately held companies and has served on the Board of Directors since 2014.

Isabel Marey-Semper spent over 20 years in the private sector, as top executive and member of the Executive Committee of several large industrial French companies, namely Compagnie de Saint-Gobain, Stellantis N.V (formerly Group PSA Peugeot Citroen) and L’Oreal S.A. She is currently a senior advisor to the technological private equity firm Jolt Capital and also serves as director of Damae Medical, Imagine Institute, and the Inria Foundation. She is a former director of Rexel. Ms Marey-Semper has served on the Board of Directors since 2019.

Candace Matthews was the former Chief Reputation Officer for Amway Corp. Ms. Matthews also served as President of the SoftSheen-Carson, Consumer Products Division of L’Oréal USA. She is currently on the board of directors for MillerKnoll, Inc. (formerly Herman Miller, Inc.), Société BIC S.A and Spectrum Health Foundation. Matthews is a former director of Popeye’s Louisiana Kitchen Inc.  Ms. Matthews has served on the Board of Directors since 2021.

Maritza Montiel served as Deputy Chief Executive Officer and Vice Chairman of Deloitte LLP from 2011 through her retirement in 2014. During her tenure at Deloitte, Ms. Montiel served as the Advisory Partner for many engagements in which Deloitte was the principal auditor, with more than 30 years of experience in leading and performing audits of various entities. She currently is a director of McCormick & Company, Inc., Royal Caribbean Cruises Ltd. and Comcast Corporation, and serves on the board of trustees of Baptist Health South Florida Inc. Ms. Montiel has served on the Board of Directors since 2015.

B. Craig Owens is the former Chief Financial Officer and Chief Administrative Officer for Campbell Soup Company from 2008 to 2014. He is a director of Crown Holdings, Inc. and a former director of Dean Foods Company and of J. C. Penney Company, Inc. Mr. Owens has served on the Board of Directors since 2018. 

Stephan Tanda joined Aptar in February 2017 as President and CEO. Prior to joining Aptar, he served as an Executive Managing Board Director at Royal DSM NV and oversaw its $5.5 billion global Nutrition business as well as its Pharma joint ventures and business interests in the Americas. Mr. Tanda is a director of Ingredion Incorporated and was previously a director of Patheon NV until the company was sold to Thermo Fisher Scientific. Mr. Tanda has served on the Board of Directors since 2017.

Matt Trerotola has served as the Chief Executive Officer for Enovis Corporation (formerly Colfax), an innovation-driven medical technology company, since 2015, and also served as the President until April 2022. Prior to his CEO role at Enovis, Matt was the Executive Vice President and a member of the Office of the Chief Executive at DuPont de Nemours, Inc. While at DuPont, he was responsible for DuPont’s Electronics & Communications and Safety & Protection segments (2014), and he also had corporate responsibility for DuPont’s Asia-Pacific business. He currently serves on the Board of Directors for Enovis Corporation. Mr. Trerotola has served on the Board of Directors since 2022.

Ralf Wunderlich is an independent consultant and a senior advisor to private equity firms. Mr. Wunderlich is a director of Essentra PLC, Huhtamaki Oyj and Shepherd Building Group Ltd. Previously, Mr. Wunderlich served as a director of LINPAC Group and AMVIG Group. He is a former member of Amcor Limited’s Global Executive Team and former President of the business group Amcor Flexibles Asia Pacific Mr. Wunderlich has served on the Board of Directors since 2009.

Julie has over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis and is currently the Executive Chair of the Board of Directors of Mundipharma China (a global pharmaceutical leader). She previously held the positions of Global Senior Vice President and President of Greater China for Envista Holdings Corporation. She has held numerous leadership roles at Eli Lilly and Company including Senior Director, Global New Product Planning and Payer Marketing, Pricing, Reimbursement and Access of Lilly Diabetes. Prior to Eli Lilly, she was Vice President and General Manager of Asia Pacific and Japan Operations at Panomics and Affymetrix, which was acquired by Thermo Fisher Scientific. She has also served as a Board Advisor on the Board of Directors for Mars, Incorporated (a global manufacturer of confectionery, pet food and provider of animal care services) since 2019 and joined Aptar’s Board of Directors in 2023.